Infliximab(chimeric monoclonal antibody to tumor necrosis factor alpha)

Nippon rinsho. Japanese journal of clinical medicine

Volumn 60, Issue 3, 2002, Pages 480-486

  Hibi, Toshifumi ^a   Yoshizawa, Shigeo ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; INFLIXIMAB; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; CLINICAL TRIAL; CROHN DISEASE; CYTOTOXICITY; HUMAN; IMMUNOLOGY; INTESTINE FISTULA; MOUSE; PROTEIN ENGINEERING; REVIEW; RHEUMATOID ARTHRITIS; TREATMENT OUTCOME;

ANIMALS; ANTIBODIES, MONOCLONAL; ARTHRITIS, RHEUMATOID; CLINICAL TRIALS; CROHN DISEASE; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; INTESTINAL FISTULA; MICE; PROTEIN ENGINEERING; RECOMBINANT FUSION PROTEINS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036512874     PISSN: 00471852     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (15)